The first UK research study into the medical benefits of cannabis on Multiple Scelrosis has shown there is no benefit.
However there were benefits for those at the lower end of the disability scale.
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study was carried out by researchers from the Peninsula College of Medicine and Dentistry.
It enrolled nearly 500 people with MS from 27 centres around the UK, who were either given capsules containing the active ingredient of cannabis and some given a placebo.
Alison Smith, an MS sufferer took part in the trial:
More top news
The persistent Ebola infection that has re-hospitalised British nurse Pauline Cafferkey presents very little risk to others, an expert says.
A group of 'cereal offenders' have made off with £45,000 worth of Kellogg's breakfast bars after stealing a lorry full of the snacks.
One person has been killed and three others injured in a shooting at the Northern Arizona University.